Successful Industrial Biotechnology Entrepreneur and Researcher Brings Moe Than 20 Years of Experience to Biochemical Innovator
Houston, TX (PRWEB) February 2, 2010 -- Glycos Biotechnologies, Inc. (GlycosBio), an emerging biochemical company pioneering metabolic engineering and microbiology innovations that produce green chemicals, today announced the appointment of Daniel J. Monticello, Ph.D., as Vice President, Research and Development. In this role, Dr. Monticello will be responsible for directing the lab operations for GlycosBio, including research, development and the overall efforts associated with scale-up and commercialization of GlycosBio’s proprietary microbe technology. In addition, Dr. Monticello will be responsible for overseeing GlycosBio’s ongoing demonstration and commercialization efforts in Latin America.
“Dr. Monticello has a unique and broad set of business, management, science and technical skills not only from large, multinational biotechnology organizations but also from the start-up environment,” said Paul Campbell, Ph.D., Chief Science Officer for Glycos Biotechnologies. “His in-depth experience in metabolic engineering as well as industrial fermentations will directly impact and contribute to the ongoing development of GlycosBio’s bioconversion technologies. Dr. Moniticello is a vital addition to our team and will help GlycosBio meet our long-term scientific and business goals.”
Dr. Monticello joins GlycosBio with more than 20 years of experience in industrial biotechnology. Prior to joining GlycosBio, Dr. Monticello was Co-Founder of Molecular LogiX, Inc., an early stage biotechnology company. While at Molecular LogiX, Dr. Monticello was responsible for overseeing the day-to-day operations including finance, strategic planning, science and technology development. Before founding Molecular LogiX, Dr. Monticello was Vice President, Research and Development and Co-Founder for Energy Biosystems Corporation (ENBC). In addition to his entrepreneurial experience, Dr. Monticello held several project and research management positions for Miles, Inc., in both the Biotechnology and Enzyme Products Divisions. Dr. Monticello has contributed to more than 20 issued US patents, is an active presenter in the scientific community and has published dozens of scientific papers and articles.
"Scientific discovery and entrepreneurship have been and continue to be key drivers of my career and GlycosBio embodies both," said Monticello. "GlycosBio has created a truly unique and revolutionary technology that can change the way biofuel, oleochemical, palm oil and petrochemical producers not only create chemicals but also how they manage their business to increase revenue and profitability. GlycosBio is creating better ways to make green chemicals and biofuels to help the industry more efficiently meet its long-term fuel goals. I’m truly excited to be a part of such an innovative and talented team."
About Glycos Biotechnologies, Inc.
Glycos Biotechnologies, Inc. (GlycosBio) is an emerging biochemical company pioneering the metabolic engineering of microbial strains to consume multiple non sugar-based, low value feedstocks for the production of sustainable chemical intermediates and advanced ethanol. By designing differentiated microorganisms, GlycosBio’s bioconversion technology lowers production cost and provides a non food energy balance savings to the chemical and biofuel industries. GlycosBio is privately held with established global relationships focused on product commercialization. For more information, visit www.glycosbio.com.
# # #
Read the full story at http://www.prweb.com/releases/GlycosBio/DanMonticello/prweb3540564.htm.
Copyright©2010 Vocus, Inc.
All rights reserved